OTC:INTI | Insider Transactions | Inhibitor Therapeutics, Inc.

INTI Insider Transactions

39 retained open-market purchase and sale rows from SEC Forms 3, 4 and 5, newest first. This page shows rows 1–39; provenance stays internal.

INTI insiders transaction timeline

PurchaseSale
2006-01-10: 2 sales — SEARS SAMUEL P JR2006-04-07: 1 purchase — FREER RICHARD J2006-04-19: 1 purchase — Krueger Gerald P2006-05-15: 1 purchase — Krueger Gerald P2006-07-07: 1 sale — SEARS SAMUEL P JR2006-07-10: 1 sale — SEARS SAMUEL P JR2006-07-11: 1 sale — SEARS SAMUEL P JR2006-07-14: 2 sales — SEARS SAMUEL P JR2006-12-08: 3 sales — SEARS SAMUEL P JR2008-04-11: 1 sale — REYNOLDS THOMAS R2008-05-27: 1 sale — HARRIS ROBERT B2008-09-12: 1 sale — PharmAust Chemistry Ltd.2008-09-25: 1 purchase — FREER RICHARD J2009-04-30: 1 purchase — D'Sylva Paul2009-05-01: 1 purchase — D'Sylva Paul2009-05-04: 1 purchase — D'Sylva Paul2009-05-05: 1 purchase — D'Sylva Paul2009-05-14: 1 purchase — D'Sylva Paul2009-05-15: 1 purchase — D'Sylva Paul2009-05-29: 1 purchase — D'Sylva Paul2010-01-19: 1 sale — D'Sylva Paul2014-09-08: 1 purchase — Watson W. Mark2015-09-10: 1 purchase — ODONNELL FRANCIS E JR2015-09-10: 1 sale — HedgePath, LLC2016-06-15: 1 purchase — ODONNELL FRANCIS E JR2016-06-15: 2 sales — HedgePath, LLC, ODONNELL FRANCIS E JR2017-06-30: 1 sale — HedgePath, LLC2017-12-19: 4 purchases — Cross Stefan, Mayne Pharma Group Ltd, Mayne Pharma International Pty Ltd and 1 more2018-08-30: 1 sale — Hasara Garrison J.2019-12-02: 1 purchase — Hasara Garrison J.2019-12-12: 1 purchase — Watson W. Mark2006-01-102019-12-12
Insider profileRoleDateTransactionSharesPrice
Watson W. MarkDirector2019-12-12Purchase500.0$0.06
Hasara Garrison J.CFO and Treasurer2019-12-02Purchase13,500.0$0.07
Hasara Garrison J.CFO and Treasurer2018-08-30Sale100,000.0$0.27
Cross StefanDirector2017-12-19Purchase600,000.0$162,660.0
Mayne Pharma Group LtdTenPercentOwner2017-12-19Purchase600,000.0$162,660.0
Mayne Pharma International Pty LtdTenPercentOwner2017-12-19Purchase600,000.0$162,660.0
Mayne Pharma Ventures Pty LtdTenPercentOwner2017-12-19Purchase600,000.0$162,660.0
HedgePath, LLCTenPercentOwner2017-06-30Sale2,500,000.0—
HedgePath, LLCTenPercentOwner2016-06-15Sale2,560,000.0—
ODONNELL FRANCIS E JRExecutive Chairman2016-06-15Purchase2,560,000.0—
ODONNELL FRANCIS E JRExecutive Chairman2016-06-15Sale2,560,000.0—
HedgePath, LLCTenPercentOwner2015-09-10Sale20,000,000.0—
ODONNELL FRANCIS E JRExecutive Chairman2015-09-10Purchase20,000,000.0—
Watson W. MarkDirector2014-09-08Purchase10,000.0$0.13
D'Sylva PaulDirector2010-01-19Sale19,100.0$0.5
D'Sylva PaulDirector2009-05-29Purchase12,000.0$0.4
D'Sylva PaulDirector2009-05-15Purchase510.0$0.38
D'Sylva PaulDirector2009-05-14Purchase2,800.0$0.4
D'Sylva PaulDirector2009-05-05Purchase23,934.0$0.35
D'Sylva PaulDirector2009-05-04Purchase500.0$0.35
D'Sylva PaulDirector2009-05-01Purchase5,866.0$0.35
D'Sylva PaulDirector2009-04-30Purchase19,706.0$0.35
FREER RICHARD JCOO2008-09-25Purchase5,000.0$0.98
PharmAust Chemistry Ltd.TenPercentOwner2008-09-12Sale2,150,000.0$1.45
HARRIS ROBERT BPresident2008-05-27Sale10,000.0$1.59
REYNOLDS THOMAS RSecretary2008-04-11Sale4,000.0$2.89
SEARS SAMUEL P JRDirector2006-12-08Sale2,600.0$2.6
SEARS SAMUEL P JRDirector2006-12-08Sale600.0$2.58
SEARS SAMUEL P JRDirector2006-12-08Sale8,800.0$2.54
SEARS SAMUEL P JRDirector2006-07-14Sale6,500.0$2.69
SEARS SAMUEL P JRDirector2006-07-14Sale10,000.0$2.75
SEARS SAMUEL P JRDirector2006-07-11Sale2,500.0$2.76
SEARS SAMUEL P JRDirector2006-07-10Sale3,000.0$2.83
SEARS SAMUEL P JRDirector2006-07-07Sale10,000.0$2.82
Krueger Gerald PDirector2006-05-15Purchase2,000.0$2.6
Krueger Gerald PDirector2006-04-19Purchase1,000.0$3.25
FREER RICHARD JCOO and Chairman2006-04-07Purchase1,000.0$3.2
SEARS SAMUEL P JRDirector2006-01-10Sale2,500.0$4.64
SEARS SAMUEL P JRDirector2006-01-10Sale4,000.0$4.68